Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Higgins

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 5, 2024
Safety and efficacy of ivacaftor in infants aged 1 to less than 4 months with cystic fibrosisPaul McNally, Alvin Singh, Susanna A McColley, et al.
Respiratory Medicine|July 24, 2007
Safety and tolerability of indacaterol in asthma: a randomized, placebo-controlled 28-day studyAlexander G Chuchalin, Alla N Tsoi, Kai Richter, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 5, 2019
An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB)Margaret Rosenfeld, Steve Cunningham, William T Harris, et al.
Pediatric Pulmonology|February 3, 2015
Novel outcome measures for clinical trials in cystic fibrosisHarm A W M Tiddens, Michael Puderbach, Jose G Venegas, et al.
Thorax|May 12, 2018
Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftorLeona Bessonova, Nataliya Volkova, Mark Higgins, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 15, 2019
Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registriesNataliya Volkova, Kristin Moy, Jennifer Evans, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2014
Targeted carbon conservation at national scales with high-resolution monitoringGregory P Asner, David E Knapp, Roberta E Martin, et al.
Clinical and Translational Science|December 5, 2020
G970R-CFTR Mutation (c.2908G>C) Results Predominantly in a Splicing DefectMeredith C Fidler, Alexandra Buckley, James C Sullivan, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 5, 2024
Safety and efficacy of ivacaftor in infants aged 1 to less than 4 months with cystic fibrosisPaul McNally, Alvin Singh, Susanna A McColley, et al.
Respiratory Medicine|July 24, 2007
Safety and tolerability of indacaterol in asthma: a randomized, placebo-controlled 28-day studyAlexander G Chuchalin, Alla N Tsoi, Kai Richter, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 5, 2019
An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB)Margaret Rosenfeld, Steve Cunningham, William T Harris, et al.
Pediatric Pulmonology|February 3, 2015
Novel outcome measures for clinical trials in cystic fibrosisHarm A W M Tiddens, Michael Puderbach, Jose G Venegas, et al.
Thorax|May 12, 2018
Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftorLeona Bessonova, Nataliya Volkova, Mark Higgins, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 15, 2019
Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registriesNataliya Volkova, Kristin Moy, Jennifer Evans, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2014
Targeted carbon conservation at national scales with high-resolution monitoringGregory P Asner, David E Knapp, Roberta E Martin, et al.
Clinical and Translational Science|December 5, 2020
G970R-CFTR Mutation (c.2908G>C) Results Predominantly in a Splicing DefectMeredith C Fidler, Alexandra Buckley, James C Sullivan, et al.
Pageof 6